Arcadia Biosciences Inc

Full interview: Arcadia Biosciences makes major progress on its hemp venture to drive revenue in 2020

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made major progress on several fronts in the second quarter with its wheat, soybean, and its hemp joint venture.

Quick facts: Arcadia Biosciences Inc

Price: $5.30

Market: NASDAQ
Market Cap: $38.68 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...



Arcadia Biosciences joins forces with Legacy Ventures Hawaii in new joint...

Arcadia Biosciences Inc (NASDAQ:RKDA) CFO Matt Plavan tells Proactive the company has formed a joint venture with Legacy Ventures Hawaii, making the company vertically integrated from seed to sale. Plavan says the partnership, known as Archipelago Ventures, pairs Arcadia’s genetic expertise and...

on 08/06/2019

2 min read